The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Drug Therapy
PreviousPrevious
Volume 351:683-694 August 12, 2004 Number 7
NextNext

Treatment of von Willebrand's Disease
Pier Mannuccio Mannucci, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Von Willebrand's disease is an inherited bleeding disorder with a prevalence as high as 1 to 2 percent in the general population, according to screening studies.1,2 In contrast, estimates based on referral for symptoms of bleeding suggest a prevalence of 30 to 100 cases per million, which is similar to the prevalence of hemophilia A.1,2 The disease was first described in 1926 by the Finnish pediatrician Erik von Willebrand, who used a rowboat to make house calls to patients with the disease in the Åland archipelago. The disease is caused by the quantitative deficiency or dysfunction of von Willebrand factor, . . . [Full Text of this Article]

Classification

Laboratory Diagnosis

General Principles of Treatment

Autologous Replacement Therapy

Dosage and Routes of Administration

Clinical Efficacy

Response and Phenotypes

Adverse Effects

Allogeneic Replacement Therapy

Replacement Products

Dosage of Concentrate

Laboratory Monitoring

Antifibrinolytic Amino Acids

Reproductive Health

Menorrhagia

Management of Delivery

Alloantibodies

Acquired von Willebrand Syndrome

The Future

Conclusions


Source Information

From the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and the Department of Internal Medicine and Dermatology, Istituto di Ricovero e Cura a Carattere Scientifico Maggiore Hospital and the University of Milan, Milan.

Address reprint requests to Dr. Mannucci at Via Pace 9, 20122 Milan, Italy, or at piermannuccio.mannucci@unimi.it.


Related Letters:

Treatment of von Willebrand's Disease
Kashyap A. S., Anand K. P., Kashyap S., Tanvetyanon T., Mannucci P.M.
Extract | Full Text | PDF  
N Engl J Med 2004; 351:2345-2346, Nov 25, 2004. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.